Q32 Bio (QTTB) Capital Expenditures (2017 - 2026)
Q32 Bio (QTTB) recorded quarterly Capital Expenditures of $175000.0 in Q1 2026, down 81.79% quarter-over-quarter from $961000.0 in Q4 2025, and down 29.15% on a YoY basis from $247000.0 in Q1 2025.
Q32 Bio (QTTB) Capital Expenditures (2017 - 2026) Analysis & Trends
Q32 Bio's Capital Expenditures history runs 10 years deep, the most recent figure standing at $175000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures fell 29.15% year-over-year to $175000.0; the TTM figure through Mar 2026 stood at $889000.0 (up 329.47% YoY), while the FY2025 annual figure was $961000.0, up 1181.33% from the prior year.
- Capital Expenditures was $175000.0 for Q1 2026 at Q32 Bio, down from $961000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $1.2 million in Q2 2022 to a low of -$527000.0 in Q4 2024.
- Historically, Capital Expenditures has averaged $166733.3 across 5 years, with a median of $115000.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Capital Expenditures slumped 3283.33% in 2023, then jumped 2200.0% in 2024.
- A 5-year view of Capital Expenditures shows it stood at $9000.0 in 2022, then sank by 2222.22% to -$191000.0 in 2023, then plunged by 175.92% to -$527000.0 in 2024, then jumped by 282.35% to $961000.0 in 2025, then tumbled by 81.79% to $175000.0 in 2026.
- The last three Capital Expenditures figures came in at $175000.0 (Q1 2026), $961000.0 (Q4 2025), and -$247000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Q32 Bio | 167.59 Mn | 116.84 Mn | - | 175,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 175,000.00 |
| Mar 31, 2026 | 175,000.00 |
| Dec 31, 2025 | 961,000.00 |
| Dec 31, 2025 | 961,000.00 |
| Jun 30, 2025 | -247,000.00 |
| Jun 30, 2025 | -247,000.00 |
| Mar 31, 2025 | 247,000.00 |
| Mar 31, 2025 | 247,000.00 |
| Dec 31, 2024 | -527,000.00 |
| Dec 31, 2024 | -527,000.00 |
| Sep 30, 2024 | 264,000.00 |
| Sep 30, 2024 | 264,000.00 |
| Jun 30, 2024 | 223,000.00 |
| Jun 30, 2024 | 223,000.00 |
| Mar 31, 2024 | 115,000.00 |
| Mar 31, 2024 | 115,000.00 |
| Sep 30, 2023 | -191,000.00 |
| Sep 30, 2023 | -191,000.00 |
| Jun 30, 2023 | 191,000.00 |
| Jun 30, 2023 | 191,000.00 |